Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy. | Clin Cancer Res | 2023 | 35969170 | PubTator, text mining | PubMed |
| A Fc-VEGF chimeric fusion enhances PD-L1 immunotherapy via inducing immune reprogramming and infiltration in the immunosuppressive tumor microenvironment. | Cancer Immunol Immunother | 2023 | 35895109 | PubTator, text mining | PubMed |
| Pregnancy-Related Acute Kidney Injury: Do We Know What to Do? | Nephron | 2023 | 35793648 | PubTator, text mining | PubMed |
| Angiogenic biomarkers for the follow-up of singleton pregnancies with suspected preeclampsia. | Minerva Obstet Gynecol | 2023 | 35758095 | PubTator, text mining | PubMed |
| Circulating biomarkers for management of cancer therapeutics-related cardiac dysfunction. | Cardiovasc Res | 2023 | 35640873 | PubTator, text mining | PubMed |
| Skeletal stem cells: origins, definitions, and functions in bone development and disease. | Life Med | 2022 | 36811112 | PubTator, text mining | PubMed |
| Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE). | Lupus Sci Med | 2022 | 36755365 | PubTator, text mining | PubMed |
| A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy. | Front Endocrinol (Lausanne) | 2022 | 36714571 | PubTator, text mining | PubMed |
| Crosstalk between cancer stem cells and the tumor microenvironment drives progression of premalignant oral epithelium. | Front Oral Health | 2022 | 36704239 | PubTator, text mining | PubMed |
| Insights into the immunomodulatory regulation of matrix metalloproteinase at the maternal-fetal interface during early pregnancy and pregnancy-related diseases. | Front Immunol | 2022 | 36700222 | PubTator, text mining | PubMed |
| Current Treatments and Innovations in Diabetic Retinopathy and Diabetic Macular Edema. | Pharmaceutics | 2022 | 36678750 | PubTator, text mining | PubMed |
| Immunoregulatory framework and the role of miRNA in the pathogenesis of NSCLC - A systematic review. | Front Oncol | 2022 | 36620544 | PubTator, text mining | PubMed |
| Physiological and pathological roles of Ang II and Ang- (1-7) in the female reproductive system. | Front Endocrinol (Lausanne) | 2022 | 36619582 | PubTator, text mining | PubMed |
| Reduced expression in preterm birth of sFLT-1 and PlGF with a high sFLT-1/PlGF ratio in extracellular vesicles suggests a potential biomarker. | Front Endocrinol (Lausanne) | 2022 | 36619545 | PubTator, text mining | PubMed |
| Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors. | Front Immunol | 2022 | 36618384 | PubTator, text mining | PubMed |
| Examination of Inner Retinal Layers in Unilateral Wet Age-Related Macular Degeneration Treated with Anti-VEGF, Compared to Fellow Untreated Eyes. | Int J Mol Sci | 2022 | 36613846 | PubTator, text mining | PubMed |
| The Association of IL-17 and PlGF/sENG Ratio in Pre-Eclampsia and Adverse Pregnancy Outcomes. | Int J Environ Res Public Health | 2022 | 36613090 | PubTator, text mining | PubMed |
| APOL1 genotype associated risk for preeclampsia in African populations: Rationale and protocol design for studies in women of African ancestry in resource limited settings. | PLoS One | 2022 | 36580463 | PubTator, text mining | PubMed |
PD-1/PD-L1 inhibitors plus anti-angiogenic agents with or without chemotherapy versus PD-1/PD-L1 inhibitors plus chemotherapy as second or later-line treatment for patients with advanced non-small cell lung cancer: A real-world retrospective cohort study. | Front Immunol | 2022 | 36569915 | PubTator, text mining | PubMed |
| Early prediction and longitudinal modeling of preeclampsia from multiomics. | Patterns (N Y) | 2022 | 36569558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=17